Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme
Ubiquitin and ubiquitin-like modifiers such as SUMO play important roles in several cellular pathways that can become deregulated in cancer. Here the authors describe the structural basis for inhibition of SUMO E1 ligase by the small molecule COH000.
Saved in:
Main Authors: | Zongyang Lv, Lingmin Yuan, James H. Atkison, Katelyn M. Williams, Ramir Vega, E. Hampton Sessions, Daniela B. Divlianska, Christopher Davies, Yuan Chen, Shaun K. Olsen |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/790d42b1a88b44e08307e39d6b2a360c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural insights into the mechanism and E2 specificity of the RBR E3 ubiquitin ligase HHARI
by: Lingmin Yuan, et al.
Published: (2017) -
Crystal structures of an E1–E2–ubiquitin thioester mimetic reveal molecular mechanisms of transthioesterification
by: Lingmin Yuan, et al.
Published: (2021) -
Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases
by: Jacob Lauwring Andersen, et al.
Published: (2018) -
Structural insights into E1 recognition and the ubiquitin-conjugating activity of the E2 enzyme Cdc34
by: Katelyn M. Williams, et al.
Published: (2019) -
Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal
by: Li Du, et al.
Published: (2016)